2025 PRIMO | New Directions In Chemotherapy and Immunotherapy for HR+ Breast Cancer

2025 PRIMO | New Directions In Chemotherapy and Immunotherapy for HR+ Breast Cancer

Overview

NA

Target Audience

NA

This material is non‑CME, no credits are available, and a certificate will not be provided upon completion.

Faculty

Joyce O’Shaughnessy, MD

Date of Release

May 14th, 2025